Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis.
Personalization of multiple sclerosis treatments: using the chelation therapy approach.
Cross-sectional area variations of internal jugular veins during supine head rotation in multiple sclerosis patients with chronic cerebrospinal venous insufficiency: a prospective diagnostic controlled study with duplex ultrasound investigation.
Cost-utility analysis of disease-modifying drugs in relapsing-remitting multiple sclerosis in Iran.
Analysis of CYP27B1 in multiple sclerosis.
The conceptualization and development of a patient-reported neurogenic bladder symptom score.
The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases.
New Poteintial Serum Biomarkers in Multiple Sclerosis Identified by Proteomic Strategies.
Cannabidiol in Humans-The Quest for Therapeutic Targets.
[New challenges in multiple sclerosis treatment].
Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions.
Polyreactive monoclonal autoantibodies in multiple sclerosis: functional selection from phage display library and characterization by deep sequencing analysis.
Sjögren's syndrome and multiple sclerosis: Two sides of the same coin?
Hit-to-lead evaluation of a novel class of sphingosine 1-phosphate lyase inhibitors.
Development of a Human Dihydroorotate Dehydrogenase (hDHODH) Pharma-Similarity Index Approach with Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors.
Seminal vesicle fluid ameliorates experimental autoimmune encephalomyelitis by increasing FoxP3(+) regulatory T-cell numbers.
Circulating Levels of Interleukin-35 in Patients with Multiple Sclerosis: Evaluation of the Influences of FOXP3 Gene Polymorphism and Treatment Program.
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP).
Treatment of acute optic neuritis and vision complaints in multiple sclerosis.
Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America.
[STUDY ON RELATIONSHIP BETWEEN DIFFUSION TENSOR IMAGING AND VISUAL EVOKED POTENTIAL IN VISUAL PATHWAY OF NEUROMYELITIS OPTICA].
Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration.
Effects of whole-body vibration training on physical function in patients with Multiple Sclerosis.
Erratum: microRNA dysregulation in multiple sclerosis.
Neural Crest Cells Isolated from the Bone Marrow of Transgenic Mice Express JCV T-Antigen.
Pages
« first
‹ previous
…
523
524
525
526
527
528
529
530
531
…
next ›
last »